Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts

Fig. 2

Diagnostic performance of CSF p-tau235 when discriminating syndromic groups stratified by CSF amyloidosis. Both in a the Paris cohort and b the BIODEGMAR cohort CSF p-tau235 displayed high accuracies differentiating dementia Aβ+ from dementia Aβ− and MCI Aβ+ from MCI Aβ−, similar to CSF p-tau181 and p-tau231, and lower than CSF p-tau217. Data information: forest plots showing AUC values from ROC analysis (CI95% available in Supplementary Table 4). Comparisons of AUC values between CSF p-tau235 and other available CSF p-tau biomarkers were determined using DeLong test (significance is indicated in bold)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193